Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort.

Publikation

Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort.

Wissenschaftlicher Artikel/Review - 26.12.2022

Krauss Philipp, Steininger Kathrin, Motov Stefan, Sommer Bjoern, Bonk Maximilian Niklas, Cortes Abraham, Wolfert Christina, Stueben Georg, Shiban Ehab, Kahl Klaus Henning

Zitation

Krauss P, Steininger K, Motov S, Sommer B, Bonk M, Cortes A, Wolfert C, Stueben G, Shiban E, Kahl K. Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort. Front Surg 2022; 9:1071804.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Surg 2022; 9

Veröffentlichungsdatum

26.12.2022

ISSN (Druck)

2296-875X

Seiten

1071804

Kurzbeschreibung/Zielsetzung

Intraoperative Radiotherapy (ioRT) is an emerging treatment option in oncologic surgery for various diseases including intraaxial brain lesions to improve surgical outcome and accelerate the adjuvant oncologic therapy. Despite its use in glioma surgery, the application and data regarding ioRT in the treatment of brain metastases (BMs) is sparse. Here were report the largest series of supratentorial BMs treated with resection and ioRT according to functional outcome and adverse events.